Question 1

Does Raymond James Financial own KLRS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Raymond James Financial holds 97,164 shares of KLRS (Kalaris Therapeutics), worth $395,457.

Question 2

How many shares of KLRS does Raymond James Financial own?

Accepted Answer

As of its Q2 2026 13F, Raymond James Financial holds 97,164 shares of KLRS (Kalaris Therapeutics).

Question 3

What is Raymond James Financial's KLRS position worth?

Accepted Answer

As of its Q2 2026 13F, Raymond James Financial's KLRS position is worth $395,457.

Question 4

Is Raymond James Financial buying or selling KLRS?

Accepted Answer

In Q2 2026, Raymond James Financial reduced its KLRS position by 21,723 shares (-18.3%).

Question 5

When did Raymond James Financial first buy KLRS?

Accepted Answer

Raymond James Financial first reported KLRS in its Q2 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	97,164	-18.3%	$395,457	0.0%	$4.07	0
2026-Q1	Increased	118,887	+34.4%	$685,978	0.0%	$9.42	32
2025-Q4	New	88,436	-	$746,400	0.0%	$8.38	34
2025-Q3	Exited	0	-100.0%	$0	0.0%	$6.35	0
2025-Q2	New	2,629	-	$7,019	0.0%	$2.62	25

KLRS5 quarters

KLRS
5 quarters